Impressive regression of primary liver cancer after treatment with sirolimus.
Rizell
Magnus
M
Cahlin
Christian
C
Friman
Styrbjörn
S
Hafström
Lo
L
Lönn
Lars
L
Olausson
Michael
M
Lindner
Per
P
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009365:Neoplasm Regression, Spontaneous / Q000276:immunology / Q000473:pathology; D020123:Sirolimus / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D020123:Sirolimus